drugset / Trial / NCT03992365

Study of the Efficacy and Safety of Quiklean® and Klean-Prep With Dulcolax® for the Bowel Preparation Prior to Colonoscopy

NCT03992365

Phase 3 Completed 472 enrolled Universal Integrated Corp.
RandomizedParallel-groupSingle-blindTreatment

Summary

The objective is to demonstrate that investigational drug, Quiklean®, is not inferior to standard comparator, Klean-Prep with Dulcolax®, with respect to the overall quality of bowel preparation in subjects undergoing colonoscopy.

Timeline

Start
2019-06-10
Primary completion
2019-10-15
Completion
2020-01-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bisacodyl Small molecule 5 mg
Comparator Klean-Prep® Other / unclassified 1000 ml Oral
Subject Quiklean® Unknown Oral

Indications

No indication recorded.